About Us
Classes Of Business

HMO Reinsurance

Provider Excess Of Less

Medical Reinsurance

Employer Stop Loss

Client Captive Programs

Cell & Gene Therapy
Cost Containment
News
Contact Us

News
Mesoblast Plans New GvHD Trial After Another FDA Rejection

on August 1, 2023 (updated October 5, 2023) | Category: News

Mesoblast Plans New GvHD Trial After Another FDA Rejection

Click here to download PDF